Management of bowel obstruction in patients with stage IV cancer: Predictors of outcome after surgery

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 707-714

  Francescutti, Valerie ^a   Miller, Austin ^a   Satchidanand, Yashodhara ^a   Alvarez Perez, Amy ^a   Dunn, Kelli Bullard ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; METOCLOPRAMIDE; MORPHINE; OCTREOTIDE; ONDANSETRON; OXYCODONE; PROCHLORPERAZINE MALEATE; STEROID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BILE DUCT CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMATOLOGIC MALIGNANCY; HUMAN; INTESTINE OBSTRUCTION; INTESTINE SURGERY; LENGTH OF STAY; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; MEDICAL RECORD REVIEW; MORBIDITY; NASOGASTRIC TUBE; NAUSEA; NEOPLASM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SURVIVAL TIME; TOTAL PARENTERAL NUTRITION; UROGENITAL TRACT CANCER;

DISEASE MANAGEMENT; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL OBSTRUCTION; MALE; MORBIDITY; NEOPLASM STAGING; NEOPLASMS; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84875212000     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2662-2     Document Type: Article

References (18)

1. WH Tseng X Yang H Wang SR Martinez SL Chen 2011 Meyers, et al. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention Ann Surg. 254 333 338 21677562 10.1097/SLA.0b013e31822513ed
2. CI Ripamonti AM Easson H Gerdes 2008 Management of malignant bowel obstruction Eur J Cancer. 44 1105 1115 18359221 10.1016/j.ejca.2008.02.028
3. R Anthony R Baron S Mercadante S Green D Chi J Cunningham, et al. 2007 Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction J Pain Symptom Manage. 34 S49 S59 17544243 10.1016/j.jpainsymman.2007.04.011
4. C Ripamonti F De Conno V Ventafridda B Rossi MJ Baines 1993 Management of bowel obstruction in advanced and terminal cancer patients Ann Oncol. 4 15 21 8435356 1:STN:280:DyaK3s7mvVKksg%3D%3D
5. ADM Turnbull J Guerra HF Starnes 1989 Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin J Clin Oncol. 7 381 386 2918333 1:STN:280:DyaL1M7ktV2htQ%3D%3D
6. I Grossman JM Klaase JKA Avenarius IHJT de Hingh WJB Mastboom T Wiggers 2011 The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer BMC Cancer. 11 433 10.1186/1471-2407-11-433
7. H Legendre F Vanhuyse FX Caroli-Bosc JC Pector 2001 Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction EJSO. 27 362 367 10.1053/ejso.2001.1120
8. K Moore Dalal MJ Gollub TJ Miner WD Wong H Gerdes MA Schattner DP Jaques 2011 Temple LKF. Management of patients with malignant bowel obstruction and stage IV colorectal cancer J Pall Med. 14 822 828 10.1089/jpm.2010.0506
9. DJ Feuer KE Broadley JH Shepherd DPJ Barton 1999 Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer Gynecol Oncol. 75 313 322 10600282 10.1006/gyno.1999. 5594 1:STN:280:DC%2BD3c%2FmvFGitQ%3D%3D
10. TJ Miner MF Brennan DP Jaques 2004 A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer Ann Surg. 240 719 727 15383799
11. A Soriano MP Davis 2011 Malignant bowel obstruction: individualized treatment near the end of life Clev Clin J Med. 78 197 206 10.3949/ccjm.78a. 10052
12. HJ Lee SP Hong JH Cheon TI Kim BS Min NK Kim, et al. 2011 Long-term outcome of palliative therapy for malignant colorectal obstruction in patients with unresectable metastatic colorectal cancers: endoscopic stenting versus surgery Gastrointest Endosc. 73 535 542 21257165 10.1016/j.gie.2010.10.052
13. SF Khuri J Daley W Henderson G Barbour P Lowry G Irvin, et al. 1995 The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care J Am Coll Surg. 180 519 531 7749526 1:STN:280:DyaK2M3mvVGqtA%3D%3D
14. FC Wright A Chakraborty L Helyer V Moravan D Selby 2010 Predictors of survival in patients with non-curative stage IV cancer and malignant bowel obstruction J Surg Oncol. 101 425 429 20112263 10.1002/jso.21559 1:STN:280:DC%2BC3c3is1Sgug%3D%3D
15. BD Badgwell K Smith P Liu E Bruera SA Curley JN Cormier 2009 Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation Support Care Cancer. 17 727 734 19083026 10.1007/s00520-008-0554-6
16. A Chakraborty D Selby K Gardiner J Myers V Moravan F Wright 2011 Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years J Pain Symptom Manage. 41 412 420 21131167 10.1016/j.jpainsymman.2010.05.007
17. SM Weiss JM Skibber FE Rosato 1984 Bowel obstruction in cancer patients: performance status as a predictor of survival J Surg Oncol. 25 15 17 6694387 10.1002/jso.2930250105 1:STN:280:DyaL2c7hs1Shsw%3D%3D
18. G Angelelli M Moschetta T Cosmo F Binetti A Scardapane AA Ianora 2012 CT diagnosis of the nature of bowel obstruction: morphological evaluation of the transition point Radiol Med. 117 749 758 22228127 10.1007/s11547-011-0770-x 1:STN:280:DC%2BC38vgtVSiug%3D%3D